Complementary pharmacokinetic measures to further define the profile of once-daily OROS hydromorphone ER during single-dose and steady-state dosing

Por Devarakonda, Krishna, Vandenbossche, Joris, Richarz, Ute
Publicado em 2013

Transdermal fentanyl for the treatment of pain caused by osteoarthritis of the knee or hip: an open, multicentre study

Por Le Loët, Xavier, Pavelka, Karel, Richarz, Ute
Publicado em 2005

Repeat-dose steady-state pharmacokinetic evaluation of once-daily hydromorphone extended-release (OROS(®) hydromorphone ER) in patients with chronic pain

Por Vandenbossche, Joris, Richarz, Ute, Richards, Henry M
Publicado em 2012

Galantamine versus donepezil in Chinese patients with Alzheimer’s disease: results from a randomized, double-blind study

Por Zhang, Zhenxin, Yu, Lu, Gaudig, Maren, Schäuble, Barbara, Richarz, Ute
Publicado em 2012

Predicting long-term response to strong opioids in patients with low back pain: findings from a randomized, controlled trial of transdermal fentanyl and morphine

Por Kalso, Eija, Simpson, Karen H, Slappendel, Robert, Dejonckheere, Joachim, Richarz, Ute
Publicado em 2007

A Phase IIIb, Multicentre, Randomised, Parallel-Group, Placebo-Controlled, Double-Blind Study to Investigate the Efficacy and Safety of OROS Hydromorphone in Subjects with Moderate...

Por Vojtaššák, Jozef, Vojtaššák, Jozef, Jacobs, Adam, Rynn, Leonie, Waechter, Sandra, Richarz, Ute
Publicado em 2011